Claude Chevillard

1.5k total citations
85 papers, 1.2k citations indexed

About

Claude Chevillard is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Claude Chevillard has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Physiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Claude Chevillard's work include Nitric Oxide and Endothelin Effects (21 papers), Receptor Mechanisms and Signaling (16 papers) and Neuropeptides and Animal Physiology (14 papers). Claude Chevillard is often cited by papers focused on Nitric Oxide and Endothelin Effects (21 papers), Receptor Mechanisms and Signaling (16 papers) and Neuropeptides and Animal Physiology (14 papers). Claude Chevillard collaborates with scholars based in France, United States and Czechia. Claude Chevillard's co-authors include Juan M. Saavedra, M Mathieu, Daniel Vittet, Julio Fernandez‐Pardal, Nicholas Barden, Juan M. Saavedra, Maura Mathieu, François Laliberté, Jean‐Marie Launay and Nathalie C. Guérineau and has published in prestigious journals such as Science, Journal of Neuroscience and Biochemical Journal.

In The Last Decade

Claude Chevillard

83 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude Chevillard France 19 533 330 305 205 196 85 1.2k
Anita Israel Venezuela 21 600 1.1× 490 1.5× 281 0.9× 166 0.8× 164 0.8× 91 1.2k
Dennis P. Healy United States 25 622 1.2× 637 1.9× 456 1.5× 125 0.6× 127 0.6× 57 1.4k
Roger Boucher Canada 15 361 0.7× 437 1.3× 154 0.5× 129 0.6× 107 0.5× 26 1.1k
J W Funder Australia 20 455 0.9× 148 0.4× 292 1.0× 116 0.6× 84 0.4× 45 1.5k
Philip Posner United States 17 744 1.4× 754 2.3× 297 1.0× 156 0.8× 159 0.8× 50 1.2k
Paola G. Andreis Italy 23 558 1.0× 135 0.4× 402 1.3× 329 1.6× 82 0.4× 66 1.6k
Ursula Ganten Germany 28 868 1.6× 1.2k 3.6× 304 1.0× 477 2.3× 135 0.7× 63 2.4k
Than-Vinh Dam Canada 15 743 1.4× 236 0.7× 587 1.9× 313 1.5× 82 0.4× 19 1.2k
Toshio Kaneko Japan 25 773 1.5× 58 0.2× 464 1.5× 254 1.2× 143 0.7× 77 1.8k
J. Alberto Olivares‐Reyes Mexico 21 759 1.4× 272 0.8× 280 0.9× 217 1.1× 102 0.5× 45 1.5k

Countries citing papers authored by Claude Chevillard

Since Specialization
Citations

This map shows the geographic impact of Claude Chevillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Chevillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Chevillard more than expected).

Fields of papers citing papers by Claude Chevillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Chevillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Chevillard. The network helps show where Claude Chevillard may publish in the future.

Co-authorship network of co-authors of Claude Chevillard

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Chevillard. A scholar is included among the top collaborators of Claude Chevillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Chevillard. Claude Chevillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cirillo, R, Matthias Schwarz, Anna Quattropani, et al.. (2003). Pharmacology of (2 S,4 Z)-N-[(2 S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a New Potent and Selective Nonpeptide Antagonist of the Oxytocin Receptor. Journal of Pharmacology and Experimental Therapeutics. 306(1). 253–261. 28 indexed citations
2.
Michel, A., et al.. (1999). Antiproliferative, Differentiating and Apoptotic Effects Elicited by Imidazo[1,2-a]pyrazine Derivatives. General Pharmacology The Vascular System. 32(1). 135–141. 10 indexed citations
3.
Mathieu, Maura, Dalil Hamroun, Jean‐Marie Launay, & Claude Chevillard. (1998). Human Bone Marrow Platelet Progenitors Express and Release Endothelin-1. Journal of Cardiovascular Pharmacology. 31. S509–S511. 2 indexed citations
4.
Hamroun, Dalil, et al.. (1998). Change of endothelin receptor subtype in the MEG-01 human megakaryoblastic cell line. European Journal of Pharmacology. 344(2-3). 307–312. 2 indexed citations
5.
Pouzeratte, Y., et al.. (1998). Signaling Mechanisms Induced by Endothelin Agonists in Human Adrenal Glomerulosa Cells. Journal of Cardiovascular Pharmacology. 31. S501–S503. 5 indexed citations
6.
Michel, Alain, et al.. (1997). Apoptotic effects of imidazo[1,2-a]pyrazine derivatives in the human Dami cell line. European Journal of Pharmacology. 320(2-3). 215–221. 5 indexed citations
7.
Michel, Alain, et al.. (1997). Modulation of the Megakaryoblastic Dami Cell Line Differentiation by Phosphodiesterase Inhibitors and Imidazo[1,2‐a]pyrazine Derivatives. Pharmacology & Toxicology. 80(6). 286–289. 1 indexed citations
8.
Michel, Alain, et al.. (1997). Antiproliferative effects of imidazo[1,2-β]pyrazine derivatives on the dami cell line. Biochemical Pharmacology. 54(3). 365–371. 3 indexed citations
9.
Michel, Alain, et al.. (1997). Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the dami cell line. Biochemical Pharmacology. 53(8). 1141–1147. 9 indexed citations
10.
Mendre, Christiane, et al.. (1996). Endothelin receptor synthetic N-terminal fragment interacts with the receptor itself. Peptides. 17(3). 521–526. 1 indexed citations
11.
Jouquey, Simone, et al.. (1995). Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats. Neuropharmacology. 34(12). 1689–1692. 29 indexed citations
12.
Laliberté, Martin, et al.. (1994). Localization of angiotensin-converting enzyme (ACE) mRNA in rabbit gastric mucosa by in situ hybridization.. Journal of Histochemistry & Cytochemistry. 42(2). 197–201. 8 indexed citations
13.
Chevillard, Claude, et al.. (1993). Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line. Molecular and Cellular Endocrinology. 93(1). 23–29. 18 indexed citations
14.
Laliberté, Martin, Christophe Duperray, Frédéric Hollande, et al.. (1993). Expression of angiotensin I converting enzyme mRNA in rabbit gastric epithelial cells. Molecular and Cellular Endocrinology. 92(2). 167–174. 10 indexed citations
15.
Vittet, Daniel, M. Mathieu, Jean‐Marie Launay, & Claude Chevillard. (1992). Thrombin inhibits proliferation of the human megakaryoblastic MEG‐01 cell line: A possible involvement of a cyclic‐AMP dependent mechanism. Journal of Cellular Physiology. 150(1). 65–75. 18 indexed citations
16.
Laliberté, François, et al.. (1991). Angiotensin I converting enzyme in gastric mucosa of the rabbit: localization by autoradiography, immunofluorescence, and immunoelectron microscopy.. Journal of Histochemistry & Cytochemistry. 39(11). 1519–1529. 6 indexed citations
17.
Chevillard, Claude, et al.. (1989). Cardiovascular Actions and Tissue-Converting Enzyme Inhibitory Effects of Chronic Enalapril and Trandolapril Treatment of Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 14(2). 297–301. 22 indexed citations
18.
Vittet, Daniel, B. Cantau, M Mathieu, & Claude Chevillard. (1988). Properties of vasopressin-activated human platelet high affinity GTPase. Biochemical and Biophysical Research Communications. 154(1). 213–218. 3 indexed citations
19.
Reach, G., et al.. (1980). Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.. BMJ. 280(6227). 1300.2–1301. 23 indexed citations
20.
Ménard, Joël, et al.. (1973). Lack of antihypertensive effects of chronic administration of DL-propranolol in Grollman rats.. PubMed. 202(2). 298–303. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita Israel Breakdown of academic impact, for papers by Dennis P. Healy Breakdown of academic impact, for papers by Roger Boucher Breakdown of academic impact, for papers by J W Funder Breakdown of academic impact, for papers by Philip Posner Breakdown of academic impact, for papers by Paola G. Andreis Breakdown of academic impact, for papers by Ursula Ganten Breakdown of academic impact, for papers by Than-Vinh Dam Breakdown of academic impact, for papers by Toshio Kaneko Breakdown of academic impact, for papers by J. Alberto Olivares‐Reyes
Rankless by CCL
2026